Abstract |
Conventional HIV T cell vaccine strategies have not been successful in containing acute peak viremia, nor in providing long-term control. We immunized rhesus macaques intramuscularly and rectally using a heterologous adenovirus vectored SIV vaccine regimen encoding normally weakly immunogenic tat, vif, rev and vpr antigens fused to the MHC class II associated invariant chain. Immunizations induced broad T cell responses in all vaccinees. Following up to 10 repeated low-dose intrarectal challenges, vaccinees suppressed early viral replication (P=0.01) and prevented the peak viremia in 5/6 animals. Despite consistently undetectable viremia in 2 out of 6 vaccinees, all animals showed evidence of infection induced immune responses indicating that infection had taken place. Vaccinees, with and without detectable viremia better preserved their rectal CD4+ T cell population and had reduced immune hyperactivation as measured by naïve T cell depletion, Ki-67 and PD-1 expression on T cells. These results indicate that vaccination towards SIV accessory antigens vaccine can provide a level of acute control of SIV replication with a suggestion of beneficial immunological consequences in infected animals of unknown long-term significance. In conclusion, our studies demonstrate that a vaccine encoding subdominant antigens not normally associated with virus control can exert a significant impact on acute peak viremia.
|
Authors | Huanbin Xu, Anne-Marie Andersson, Emeline Ragonnaud, Ditte Boilesen, Anders Tolver, Benjamin Anderschou Holbech Jensen, James L Blanchard, Alfredo Nicosia, Antonella Folgori, Stefano Colloca, Riccardo Cortese, Allan Randrup Thomsen, Jan Pravsgaard Christensen, Ronald S Veazey, Peter Johannes Holst |
Journal | EBioMedicine
(EBioMedicine)
Vol. 18
Pg. 204-215
(Apr 2017)
ISSN: 2352-3964 [Electronic] Netherlands |
PMID | 28302457
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Antigens, Heterophile
- SAIDS Vaccines
|
Topics |
- Adenoviridae
(genetics)
- Animals
- Antigens, Heterophile
(genetics, immunology, metabolism)
- CD4-Positive T-Lymphocytes
(cytology, immunology)
- CD8-Positive T-Lymphocytes
(cytology, immunology)
- Genetic Vectors
(genetics, immunology, metabolism)
- HEK293 Cells
- Humans
- Macaca mulatta
- Mice
- Retroviruses, Simian
(physiology)
- SAIDS Vaccines
(immunology)
- Viremia
(immunology, prevention & control)
- Virus Replication
(physiology)
|